M. Machwate

1.0k citations
14 papers · 865 indexed · h-index 13
Topics
Bone Metabolism and Diseases (6 papers)Bone health and treatments (5 papers)Growth Hormone and Insulin-like Growth Factors (4 papers)

In The Last Decade

M. Machwate

13 papers receiving 842 citations

Peers

M. Machwate
Comparison fields: 5 of 77
  • Molecular Biology 526
  • Oncology 273
  • Orthopedics and Sports Medicine 169
  • Pharmacology 152
  • Genetics 114
Replace Weiguang Zhao with:
Weiguang Zhao United States
D L Goad United States
Isao Inoki Japan
Shibing Yu United States
Merrilee R. Flannery United States
Kent Z.Q. Wang United States
Helmut Glantschnig Austria
May Kung Sutherland United States
Dorothy Hu United States
Miwa Yamazaki Japan
M. Machwate relative to Weiguang Zhao United States Weiguang Zhao's profile →
Citations per field
00.5×1.5×
Weiguang Zhao · 1×
Citations per year

Countries citing papers authored by M. Machwate

Since Specialization
Citations

This map shows the geographic impact of M. Machwate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Machwate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Machwate more than expected).

Fields of papers citing papers by M. Machwate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Machwate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Machwate. The network helps show where M. Machwate may publish in the future.

Co-authorship network of co-authors of M. Machwate

This figure shows the co-authorship network connecting the top 25 collaborators of M. Machwate. A scholar is included among the top collaborators of M. Machwate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Machwate. M. Machwate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 36
2 47
3 17
4 144
5 52
6 213
7 19
8 56
9 43
10 1
11 38
12 109
13 25
14 65

About M. Machwate

M. Machwate is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Orthopedics and Sports Medicine, having authored 14 papers that have together received 865 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (169 citations), Immunology and Allergy (97 citations) and Oncology (273 citations). M. Machwate has collaborated with scholars based in France, United States and Israel. Frequent co-authors include Gideon A. Rodan, Pierre J. Marie, Xavier Holy, E. Zérath, Le T. Duong, Päivi T. Lakkakorpi, I. Nakamura, Rose Marie Nagy, Sevgi B. Rodan and Satoru Harada. Their work appears in journals such as Journal of Clinical Investigation, Endocrinology and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026